Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Interaction between the autophagy protein Beclin 1 and Na+,K+-ATPase during starvation, exercise, and ischemia
Álvaro F. Fernández, Yang Liu, Vanessa Ginet, Mingjun Shi, Jihoon Nah, Zhongju Zou, Anwu Zhou, Bruce A. Posner, Guanghua Xiao, Marion Tanguy, Valérie Paradis, Junichi Sadoshima, Pierre-Emmanuel Rautou, Julien Puyal, Ming Chang Hu, Beth Levine
Álvaro F. Fernández, Yang Liu, Vanessa Ginet, Mingjun Shi, Jihoon Nah, Zhongju Zou, Anwu Zhou, Bruce A. Posner, Guanghua Xiao, Marion Tanguy, Valérie Paradis, Junichi Sadoshima, Pierre-Emmanuel Rautou, Julien Puyal, Ming Chang Hu, Beth Levine
View: Text | PDF
Research Article Cell biology

Interaction between the autophagy protein Beclin 1 and Na+,K+-ATPase during starvation, exercise, and ischemia

  • Text
  • PDF
Abstract

Autosis is a distinct form of cell death that requires both autophagy genes and the Na+,K+-ATPase pump. However, the relationship between the autophagy machinery and Na+,K+-ATPase is unknown. We explored the hypothesis that Na+,K+-ATPase interacts with the autophagy protein Beclin 1 during stress and autosis-inducing conditions. Starvation increased the Beclin 1/Na+,K+-ATPase interaction in cultured cells, and this was blocked by cardiac glycosides, inhibitors of Na+,K+-ATPase. Increases in Beclin 1/Na+,K+-ATPase interaction were also observed in tissues from starved mice, livers of patients with anorexia nervosa, brains of neonatal rats subjected to cerebral hypoxia-ischemia (HI), and kidneys of mice subjected to renal ischemia/reperfusion injury (IRI). Cardiac glycosides blocked the increased Beclin 1/Na+,K+-ATPase interaction during cerebral HI injury and renal IRI. In the mouse renal IRI model, cardiac glycosides reduced numbers of autotic cells in the kidney and improved clinical outcome. Moreover, blockade of endogenous cardiac glycosides increased Beclin 1/Na+,K+-ATPase interaction and autotic cell death in mouse hearts during exercise. Thus, Beclin 1/Na+,K+-ATPase interaction is increased in stress conditions, and cardiac glycosides decrease this interaction and autosis in both pathophysiological and physiological settings. This crosstalk between cellular machinery that generates and consumes energy during stress may represent a fundamental homeostatic mechanism.

Authors

Álvaro F. Fernández, Yang Liu, Vanessa Ginet, Mingjun Shi, Jihoon Nah, Zhongju Zou, Anwu Zhou, Bruce A. Posner, Guanghua Xiao, Marion Tanguy, Valérie Paradis, Junichi Sadoshima, Pierre-Emmanuel Rautou, Julien Puyal, Ming Chang Hu, Beth Levine

×

Figure 5

Endogenous cardiac glycosides regulate Beclin 1/Na+,K+-ATPase binding and autosis during exercise.

Options: View larger image (or click on image) Download as PowerPoint
Endogenous cardiac glycosides regulate Beclin 1/Na+,K+-ATPase binding an...
(A and B) Representative Western blots (A) and quantitation (B) of coimmunoprecipitation of Beclin 1 with the α subunit of Na+,K+-ATPase in hearts from mice treated with either intraperitoneal vehicle or cardiac glycoside–blocking antibody DigiFab (10 mg/kg) before 80 minutes of resting or exercise. For A, the same issue sample of the resting group without DigiFab (lane 1) was used as a control for IgG immunoprecipitation. In B, bars represent mean ± SD (n = 10 mice per group). (C and D) Representative images (C) and quantitation (D) of PLAs of Beclin 1 and the α subunit of Na+,K+-ATPase in hearts from mice treated with either intraperitoneal vehicle or cardiac glycoside–blocking antibody DigiFab (10 mg/kg) before 80 minutes of resting or exercise. In D, bars represent mean ± SEM (n = 6–8 mice per group, 10 randomly selected fields analyzed per mouse). (E and F) Representative micrographs (E) and quantitation (F) of autotic noncardiomyocyte cells in hearts from mice treated with either intraperitoneal vehicle or cardiac glycoside blocking antibody DigiFab (10 mg/kg) before resting or running until exhaustion. In F, bars represent mean ± SEM (n = 6 randomly selected areas from 3 mice per condition, more than 1,000 analyzed cells per area). Asterisk, nonspecific band. Scale bars: 10 μm (B), 1 μm (C). *P < 0.05, **P < 0.01, and ***P < 0.001; 2-way ANOVA test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts